Afon Technology, a Welsh company, is developing a non-invasive blood glucose monitoring sensor that could eliminate the need for diabetics to prick their fingers up to 80,000 times in their lifetime. The sensor is designed to be worn on the inside of the wrist and can be integrated into optional smartwatch bands. It will transmit blood glucose levels wirelessly via Bluetooth to any device with the corresponding app installed. The Afon-Sensor is expected to be available by the end of 2022 and is compatible with all smartphones, tablets, and wearables.
Diabetics who suffer from Type 1 diabetes have to measure their blood glucose levels frequently, which can be painful and inconvenient. Afon Technology’s non-invasive blood glucose monitoring sensor aims to eliminate the need for finger-pricking by providing a painless alternative. The sensor is designed to be worn on the inside of the wrist and can be integrated into optional smartwatch bands. It will transmit blood glucose levels wirelessly via Bluetooth to any device with the corresponding app installed. The Afon-Sensor is expected to be available by the end of 2022 and is compatible with all smartphones, tablets, and wearables.
The Afon-Sensor has already shown promising results in clinical trials, with Professor de Vries from the German Profil Institute for Metabolic Research stating that they were “surprised and excited by the possibilities of this technology.” The sensor is expected to be affordable due to its lack of replaceable parts, making it accessible to a wider range of diabetics. While it may take several years for all 463 million diabetics worldwide to have access to non-invasive blood glucose monitoring, the Afon-Sensor is a significant step towards making life easier for those who suffer from this condition.
